by Laura Smith | Aug 8, 2022 | Communications, Journal Club
Please join us for a conversation about a study published in 2022 in the journal Cell Death Discovery entitled: “New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts”, in which Drs. Olga and Igor Kovalchuk, and Dr. Sitbon discuss the mechanisms of a wide array of cannabis extracts in modulating receptors and inflammation in the context of COVID-19.
Laura brings extensive knowledge of the pharmaceutical industry and leads patient-focused care at Csequence. Laura’s professional experience includes over 20 years in various roles within the healthcare industry as well as training in the intentional use of plant medicine, a background in community health education, and is a grief recovery specialist. She has a unique educational background with an MBA from Yale University coupled with a MA in Spiritual Psychology from the University of Santa Monica. Laura co-founded and has been co-leading Cadence Communications & Research, a boutique healthcare firm in the pharmaceutical and biotech industry for over 10 years. Laura previously worked as an Investor Relations officer at Amgen. While there, she also held a variety of finance roles to assist marketing teams to optimize decisions related to clinical investments, lifecycle management, product sales and profitability. Prior to that, she was as Hoffmann-La Roche where she participated in their leadership development program and contributed to Roche Labs supporting product launches, business development deals, pricing and product lifecycle decisions.
